Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

13

Revenue 2017

Bristol-Myers Squibb

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bristol-Myers Squibb's 2013 sales performance.

Bristol-Myers Squibb

Keytruda claims first place in bladder cancer race

Keytruda claims first place in bladder cancer race Keytruda gets the new indication ahead of rivals in the checkpoint inhibitor class, including Bristol-Myers Squibb’s Opdivo (nivolumab), Roche’s Tecentriq (atezolizumab) and AstraZeneca’s Imfinzi (durvalumab) that are

New hires at FibroGen, Saniona and Turbine

New hires at FibroGen, Saniona and Turbine Bristol-Myers Squibb.

Merck KGaA, Pfizer’s Bavencio improves survival in bladder cancer

Merck KGaA, Pfizer’s Bavencio improves survival in bladder cancer Merck’s Keytruda (pembrolizumab), Bristol-Myers Squibb’s Opdivo (nivolumab), Roche’s Tecentriq (atezolizumab) and AstraZeneca’s Imfinzi (durvalumab) are all approved for use in bladder cancer, albeit in differing settings.

EU, US biotechs merge to create fibrosis, cancer player

EU, US biotechs merge to create fibrosis, cancer player merger. Galecto has previously attracted the attention of big pharma group Bristol-Myers Squibb, which took an  option on the company in 2014 that valued it at almost $450m, but was

GSK divests travel vaccines to Bavarian Nordic as part of strategic refocus

GSK divests travel vaccines to Bavarian Nordic as part of strategic refocus GSK can't catch up with immunotherapy leaders, such as Merck &Co’s Keytruda and Bristol-Myers Squibb’s Opdivo, but its R&D chief Hal Barron (pictured right) has still

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

ACCOMPLISH MEANINGFUL HCP ENGAGEMENT ONLINE
The art of delivering valuable customer journeys aligned to your key messages in 2020...
DEMAND DIVERSITY REPORT 01: Exploring attitudes towards clinical research among people from different ethnic groups in the UK
This report reveals insights from the people themselves, and discusses the starting points for overcoming current challenges....
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative...

Infographics